Financials

Company Profile

EPIRUS Biopharmaceuticals Inc is a United States-based company. The Company operates as a pharmaceutical preparation manufacturer.

Employees

Sector

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

18-10-09	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
18-01-30	Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q).	CI

18-10-09	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
18-01-30	Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q).	CI
18-01-19	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
18-01-17	Praxis Precision Medicines, Inc. agreed to acquire Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q) for $1 million.	CI
17-12-11	Notice of Intent of Asset Sale Filed by EPIRUS Biopharmaceuticals, Inc.	CI
16-09-19	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
16-08-05	EPIRUS Biopharmaceuticals, Inc.(OTCPK:EPRS.Q) dropped from S&P TMI Index	CI
16-08-03	EPIRUS Biopharmaceuticals, Inc.(OTCPK:EPRS.Q) dropped from NASDAQ Composite Index	CI
16-07-25	EPIRUS Biopharmaceuticals, Inc. Announces Management Resignations	CI
16-07-25	EPIRUS Biopharmaceuticals, Inc. Filed for Bankruptcy	CI
16-07-01	EPIRUS Biopharmaceuticals, Inc. Announces Executive Termination	CI
16-06-29	Polpharma S.A. completed the acquisition of EPIRUS Biopharmaceuticals (Netherlands) B.V. from EPIRUS Biopharmaceuticals, Inc..	CI
16-06-13	Polpharma S.A. entered into a binding term sheet to acquire EPIRUS Biopharmaceuticals (Netherlands) B.V. from EPIRUS Biopharmaceuticals, Inc. for $3.5 million.	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EPIRUS BIOPHARMACEUTICALS, INC.	-.--%	-.--%	-	-	26
LONZA GROUP AG	-1.03%	+5.24%	+2.94%	+9.41%	50.25B
REVOLUTION MEDICINES, INC.	+0.25%	+1.70%	+419.39%	+621.71%	40.39B
IQVIA HOLDINGS INC.	+1.10%	+7.77%	+28.18%	-3.96%	34.38B
BEONE MEDICINES AG	-0.16%	+8.42%	+28.20%	+63.00%	34.4B
CELLTRION, INC.	+1.31%	-0.56%	+5.12%	+33.90%	26.32B
ASCENDIS PHARMA A/S	-0.35%	+0.09%	-	-	16.64B
MEDPACE HOLDINGS, INC.	-3.33%	+3.15%	+71.30%	+131.94%	16.14B
EUROFINS SCIENTIFIC SE	+0.32%	+1.09%	+13.28%	+21.98%	13.71B
IONIS PHARMACEUTICALS, INC.	+3.79%	+8.88%	+106.63%	+106.63%	13.75B
Average	+0.23%	+3.27%	+84.38%	+123.08%	24.6B
Weighted average by Cap.	+0.17%	+4.10%	+95.75%	+141.29%